High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B

被引:14
|
作者
Antaki, N. [1 ]
Haffar, S. [2 ]
Deeb, S. Ali [3 ]
Assaad, F. [4 ]
Abou Harb, R. [2 ]
Zeibane, N. [5 ]
Nasserelddine, M. [6 ]
Ibrahim, N. [7 ]
Alhaj, N. [2 ]
Jabbour, E. [8 ]
Aaraj, R. [9 ]
Antaki, F. [10 ]
Kebbewar, K. [11 ]
机构
[1] St Louis Hosp, Dept Gastroenterol & Hepatol, Aleppo, Syria
[2] Mouassat Hosp, Dept Gastroenterol, Damascus, Syria
[3] Damascus Hosp, Dept Gastroenterol, Damascus, Syria
[4] Squelbiye Natl Hosp, Dept Gastroenterol, Squelbiye, Syria
[5] Med Ctr Hosp, Dept Gastroenterol, Hama, Syria
[6] Sweida Natl Hosp, Dept Gastroenterol, Sweida, Syria
[7] Omaya Hosp, Dept Gastroenterol, Damascus, Syria
[8] Tabiyate Hosp, Dept Gastroenterol, Latakia, Syria
[9] Homs Natl Hosp, Dept Gastroenterol, Homs, Syria
[10] Wayne State Univ, Dept Gastroenterol, John D Dingell VA Med Ctr, Detroit, MI USA
[11] St Louis Hosp, Dept Lab Med, Aleppo, Syria
来源
EPIDEMIOLOGY AND INFECTION | 2010年 / 138卷 / 01期
关键词
Genotype D; genotype distribution; hepatitis B; HBeAg negative; Syria; VIRUS GENOTYPES; NATURAL-HISTORY; LAMIVUDINE; INFECTION; FREQUENCY;
D O I
10.1017/S0950268809990288
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hepatitis B virus (HBV) genotype D and hepatitis B e antigen (HBeAg) negative chronic hepatitis are the most prevalent in Mediterranean countries. No data have ever been published oil their prevalence in Syria, a country of intermediate endemicity for HBV. The aims of the current study were to determine the HBV genotype distribution in Syria, the prevalence of HBeAg-positive and HBeAg-negative chronic hepatitis and to analyse the clinical characteristics of each group. A total of 220 patients were included. Ninety-seven percent of the patients were of genotype D, and 72% were HBeAg negative. The HBeAg-negative patients were older, had a lower viral load, had more cirrhosis and the mode of contamination was known less than for HBeAg-positive patients. These findings have major implications in understanding the natural history of the infection and are of great relevance in the choice of therapy.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 50 条
  • [31] Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA
    Cai, Jingyao
    Wu, Weimin
    Wu, Jiali
    Chen, Zhiyang
    Wu, Ziwei
    Tang, Yamei
    Hu, Min
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (01)
  • [32] Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection
    Papatheodoridis, George V.
    Manesis, Emanuel K.
    Manolakopoulos, Spilios
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2007, 46 (02) : 606 - 607
  • [33] Hepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen-negative chronic hepatitis B
    Striki, Athanasia
    Manolakopoulos, Spilios
    Deutsch, Melanie
    Kourikou, Anastasia
    Kontos, George
    Kranidioti, Hariklia
    Hadziyannis, Emilia
    Papatheodoridis, George
    [J]. LIVER INTERNATIONAL, 2017, 37 (11) : 1642 - 1650
  • [34] Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients
    Kaneko, Shun
    Kurosaki, Masayuki
    Inada, Kento
    Kirino, Sakura
    Hayakawa, Yuka
    Yamashita, Koji
    Osawa, Leona
    Sekiguchi, Shuhei
    Higuchi, Mayu
    Takaura, Kenta
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Itakura, Jun
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2943 - 2951
  • [35] Naive hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
    Riveiro-Barciela, Mar
    Marcos-Fosch, Cristina
    Martinez-Valle, Fernando
    Bronte, Fabrizio
    Orozco, Olimpia
    Sanz-Perez, Isidro
    Torres, Daniele
    Salcedo, Maria-Teresa
    Petta, Salvatore
    Esteban, Rafael
    Craxi, Antonio
    Buti, Maria
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (30) : 5112 - 5125
  • [36] CLINICAL IMPACT OF CONTINUATION VERSUS CESSATION OF ANTIVIRAL THERAPY IN HEPATITIS B "E" ANTIGEN-NEGATIVE CHRONIC HEPATITIS B: A MODELING STUDY WITH IMPLICATIONS FOR HEPATITIS B CURE
    Mohareb, Amir M.
    Ezaz, Ghideon
    Kim, Arthur Y.
    Freedberg, Kenneth A.
    Boyd, Anders
    Hyle, Emily P.
    [J]. HEPATOLOGY, 2023, 78 : S455 - S456
  • [37] Correlation of noninvasive markers with significant liver fibrosis in patients with hepatitis B e antigen-negative chronic hepatitis B
    Lee, I-C
    Huang, Y-H
    Chan, C-C
    Lai, C-R
    Huo, T-I
    Lee, P-C
    Su, C-W
    Hung, H. H.
    Lin, H-C
    Lee, S-D
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A184 - A185
  • [38] Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study
    Zahari Krastev
    Diana Petrova
    Iskren Kotzev
    Mustafa Kemal Celen
    Meryl Mendelson
    Richa Chandra
    Priti Pandey
    Kamal Hamed
    [J]. World Journal of Hepatology, 2016, (32) : 1402 - 1413
  • [39] Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
    Ha, Nghiem B.
    Ha, Nghi B.
    Garcia, Ruel T.
    Trinh, Huy N.
    Chaung, Kevin T.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2423 - 2431
  • [40] Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
    Nghiem B. Ha
    Nghi B. Ha
    Ruel T. Garcia
    Huy N. Trinh
    Kevin T. Chaung
    Huy A. Nguyen
    Khanh K. Nguyen
    Brian S. Levitt
    Mindie H. Nguyen
    [J]. Digestive Diseases and Sciences, 2011, 56 : 2423 - 2431